Literature DB >> 12854511

Comparison of glucan detection and galactomannan enzyme immunoassay in gastrointestinal and systemic murine candidiasis.

Thomas Nichterlein1, Dieter Buchheidt, Andreas Hein, Klaus-Peter Becker, Korinna Mosbach, Marianne Kretschmar.   

Abstract

Mouse models of systemic and gastrointestinal infection with the yeast Candida albicans were used to investigate the ability of a commercial mannan antigen enzyme immunoassay and a commercial (1-->3) beta-D-glucan limulus assay to detect systemic infection and to differentiate between colonization and infection. Both assays were positive in all i.v. infected mice and negative in all uninfected control mice. In gastrointestinal infection both tests were positive whenever organ cultures were positive. In colonized mice with no detectable dissemination, there were mostly negative results with the glucan assay whereas the mannan assay was positive or intermediate in all colonized mice. Therefore, in the mouse model used, glucan detection appeared to be superior for differentiation between colonization and dissemination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12854511     DOI: 10.1016/s0732-8893(03)00038-5

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  3 in total

Review 1.  Candida peritonitis: an update on the latest research and treatments.

Authors:  Herman Anthony Carneiro; Anastasios Mavrakis; Eleftherios Mylonakis
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

2.  Detection of Candida albicans by culture, serology and PCR in clinical specimens from patients with ulcerative colitis: re-evaluation of an old hypothesis with a new perspective.

Authors:  A Kalkanci; C Tuncer; B Degertekin; A Eren; S Kustimur; M N Ilhan; A Dursun
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

3.  A Retrospective Assessment of Four Antigen Assays for the Detection of Invasive Candidiasis Among High-Risk Hospitalized Patients.

Authors:  Barbara Hartl; Iris Zeller; Angelika Manhart; Brigitte Selitsch; Cornelia Lass-Flörl; Birgit Willinger
Journal:  Mycopathologia       Date:  2018-01-22       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.